0001104659-21-149631.txt : 20211214 0001104659-21-149631.hdr.sgml : 20211214 20211214180755 ACCESSION NUMBER: 0001104659-21-149631 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211212 FILED AS OF DATE: 20211214 DATE AS OF CHANGE: 20211214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SBLENDORIO GLENN CENTRAL INDEX KEY: 0001277478 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 211492242 MAIL ADDRESS: STREET 1: 3 TIMES SQAURE, 12TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 BUSINESS PHONE: 212-845-8200 MAIL ADDRESS: STREET 1: 5 PENN PLAZA STREET 2: SUITE 2372 CITY: NEW YORK STATE: NY ZIP: 10001 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 tm2135459-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-12-12 0 0001410939 IVERIC bio, Inc. ISEE 0001277478 SBLENDORIO GLENN C/O IVERIC BIO, INC. 5 PENN PLAZA, SUITE 2372 NEW YORK NY 10001 1 1 0 0 Chief Executive Officer Common Stock 2021-12-12 4 M 0 22950 A 329292 D Common Stock 2021-12-13 4 S 0 8293 14.7449 D 320999 D Restricted Stock Units 2021-12-12 4 M 0 22950 0 D Common Stock 22950 22950 D Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units. Represents shares automatically sold pursuant to the prespecified terms of the applicable Restricted Stock Unit Agreement to satisfy the Reporting Person's minimum statutory withholding obligations with respect to the income recognized by the Reporting Person upon the vesting of the restricted stock units on December 12, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $14.50 to $14.99 on December 13, 2021 on behalf of a group of employees of the Registrant to satisfy the payment of withholding tax liability of such employees. The Reporting Person undertakes to provide upon request by the staff of the Securities Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. On December 12, 2018, the Reporting Person was granted an award of 91,800 restricted stock units, which vest with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the Registrant and the other terms and conditions of the Registrant's 2013 Stock Incentive Plan. /s/ Todd Anderman, as Attorney-in-Fact for Glenn P. Sblendorio 2021-12-14